Physician profile
Mark Weiner
NPI 1699797977
$459.05
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $113 · 2022: $102 · 2023: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65.69 | 2023 | Lumigan, Alphagan P |
| Mallinckrodt Hospital Products INC. | $62.54 | 2022-2023 | Acthar |
| Allergan, INC. | $61.40 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $49.88 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $39.54 | 2019-2021 | |
| Alcon Vision LLC | $35.24 | 2022-2023 | Hydrus Microstent |
| Horizon Therapeutics Plc | $35.01 | 2021-2022 | |
| Akorn, INC. | $22.87 | 2019 | |
| Kala Pharmaceuticals, INC. | $21.26 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $15.77 | 2019 | |
| Ucb, INC. | $15.28 | 2023 | |
| Rxsight INC | $13.23 | 2022 | |
| Oyster Point Pharma, INC. | $12.85 | 2022 | |
| Biotissue Holdings INC. | $8.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.